TY - JOUR
T1 - Identification of two novel regulated serines in the N terminus of β-catenin
AU - Van Noort, Mascha
AU - Van de Wetering, Marc
AU - Clevers, Hans
PY - 2002
Y1 - 2002
N2 - β-Catenin plays a key role in the Wnt signaling cascade. The levels of β-catenin within a cell are regulated via phosphorylation of the N terminus of β-catenin by GSK-3β. The phosphorylation leads to ubiquitination and subsequent degradation of the protein. Thus far three serines (S33, 37, 45) and one threonine (T41) are considered to be the substrates for GSK-3β phosphorylation. Indeed, these amino acids are regularly mutated in tumors, resulting in β-catenin molecules with enhanced transcriptional activity. Aligning N-terminal sequences of β-catenin homologues of different species revealed two other highly conserved serines (S23, 29), which have also been found mutated in tumors. We show that these serines are modified in the same fashion as that of the known regulatory residues. During embryogenesis, the phosphorylation status of S23 and S29 appears to be actively regulated. Nevertheless, constructs harboring the mutations found in tumors fail to show enhanced transcriptional activity or transforming properties.
AB - β-Catenin plays a key role in the Wnt signaling cascade. The levels of β-catenin within a cell are regulated via phosphorylation of the N terminus of β-catenin by GSK-3β. The phosphorylation leads to ubiquitination and subsequent degradation of the protein. Thus far three serines (S33, 37, 45) and one threonine (T41) are considered to be the substrates for GSK-3β phosphorylation. Indeed, these amino acids are regularly mutated in tumors, resulting in β-catenin molecules with enhanced transcriptional activity. Aligning N-terminal sequences of β-catenin homologues of different species revealed two other highly conserved serines (S23, 29), which have also been found mutated in tumors. We show that these serines are modified in the same fashion as that of the known regulatory residues. During embryogenesis, the phosphorylation status of S23 and S29 appears to be actively regulated. Nevertheless, constructs harboring the mutations found in tumors fail to show enhanced transcriptional activity or transforming properties.
UR - http://www.scopus.com/inward/record.url?scp=0036354655&partnerID=8YFLogxK
U2 - 10.1006/excr.2002.5520
DO - 10.1006/excr.2002.5520
M3 - Article
C2 - 12027456
AN - SCOPUS:0036354655
SN - 0014-4827
VL - 276
SP - 264
EP - 272
JO - Experimental Cell Research
JF - Experimental Cell Research
IS - 2
ER -